Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

07. Oktober 2013 08:00 ET | Quelle: Symmetry Technologies Inc.

Symmetry Technologies Inc. moves to lab test and develop its "Inducible Expression System for Biosynthetic Production of Testerone in Men"

Houston, TX, Oct. 7, 2013 (GLOBE NEWSWIRE) -- Symmetry Technologies Inc. (SMMR). is pleased to announce that it has initiated contact with a US based BioScience research and testing facility in its...
14. August 2013 16:00 ET | Quelle: Symmetry Technologies Inc.

Symmetry Technologies Inc. acquires the rights to a ground breaking technology that produces Biosynthetic Testosterone in men from A Houston PhD led Biomedical research firm. Technology estimated value up to 10 Billion Dollars.

Houston,TX, Aug. 14, 2013 (GLOBE NEWSWIRE) -- Symmetry Technologies Inc. (OTC:SMMR) is pleased to announce the acquisition from a Houston, PhD led Biomedical research firm, all work...
01. August 2013 16:00 ET | Quelle: Symmetry Technologies Inc.

Symmetry Technologies Inc. licenses a Human Rejuvenation Nutraceutical product from an FDA compliant laboratory. It will sell under the name "Resurgencell" in the yearly $200 billion USD Nutraceutical market

Houston,Tx, Aug. 1, 2013 (GLOBE NEWSWIRE) -- Symmetry Technologies Inc. (OTC:SMMR) is pleased to announce that it has licensed a Human Rejuvenation Nutraceutical product for retail sale from a US...